blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0825865

EP0825865 - TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING TESTOSTERONE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.09.2002
Database last updated on 31.08.2024
Most recent event   Tooltip04.01.2008Lapse of the patent in a contracting state
New state(s): IT		published on 06.02.2008  [2008/06]
Applicant(s)For all designated states
Hexal AG
Industriestrasse 25
83607 Holzkirchen / DE
[N/P]
Former [1998/10]For all designated states
HEXAL AG
Industriestrasse 25
D-83607 Holzkirchen / DE
Inventor(s)01 / FISCHER, Wilfried
Industriestrasse 25
D-83607 Holzkirchen / DE
02 / BRACHER, Daniel
Industriestrasse 25
D-83607 Holzkirchen / DE
[1998/10]
Representative(s)Boeters, Hans Dietrich, et al
BOETERS & LIECK
Oberanger 32
80331 München / DE
[N/P]
Former [1998/10]Boeters, Hans Dietrich, Dr., et al
Patentanwälte Boeters & Bauer, Bereiteranger 15
81541 München / DE
Application number, filing date96919765.610.05.1996
[1998/10]
WO1996EP02013
Priority number, dateDE199511714510.05.1995         Original published format: DE 19517145
[1998/10]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO9635427
Date:14.11.1996
Language:DE
[1996/50]
Type: A1 Application with search report 
No.:EP0825865
Date:04.03.1998
Language:DE
The application published by WIPO in one of the EPO official languages on 14.11.1996 takes the place of the publication of the European patent application.
[1998/10]
Type: B1 Patent specification 
No.:EP0825865
Date:07.11.2001
Language:DE
[2001/45]
Search report(s)International search report - published on:EP14.11.1996
ClassificationIPC:A61K31/565, A61K9/70
[1998/10]
CPC data not yet available
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1998/10]
Extension statesSI10.11.1997
TitleGerman:TRANSDERMALES THERAPEUTISCHES SYSTEM (TTS) ZUR VERABREICHUNG VON TESTOSTERON[1998/10]
English:TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING TESTOSTERONE[1998/10]
French:SYSTEME THERAPEUTIQUE TRANSDERMIQUE POUR ADMINISTRER DE LA TESTORERONE[1998/10]
Entry into regional phase10.11.1997National basic fee paid 
10.11.1997Designation fee(s) paid 
10.11.1997Examination fee paid 
Examination procedure29.11.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
10.11.1997Examination requested  [1998/10]
31.01.2001Despatch of communication of intention to grant (Approval: Yes)
03.05.2001Communication of intention to grant the patent
13.08.2001Fee for grant paid
13.08.2001Fee for publishing/printing paid
Opposition(s)08.08.2002No opposition filed within time limit [2002/44]
Fees paidRenewal fee
22.05.1998Renewal fee patent year 03
28.05.1999Renewal fee patent year 04
30.05.2000Renewal fee patent year 05
21.05.2001Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipFI07.11.2001
GR07.11.2001
IE07.11.2001
IT07.11.2001
PT07.02.2002
SE07.02.2002
LU10.05.2002
ES30.05.2002
[2008/06]
Former [2004/43]FI07.11.2001
GR07.11.2001
IE07.11.2001
PT07.02.2002
SE07.02.2002
LU10.05.2002
ES30.05.2002
Former [2004/39]FI07.11.2001
GR07.11.2001
PT07.02.2002
SE07.02.2002
LU10.05.2002
ES30.05.2002
Former [2004/04]FI07.11.2001
GR07.11.2001
PT07.02.2002
SE07.02.2002
ES30.05.2002
Former [2002/49]FI07.11.2001
GR07.11.2001
PT07.02.2002
SE07.02.2002
Former [2002/48]FI07.11.2001
PT07.02.2002
SE07.02.2002
Former [2002/33]FI07.11.2001
SE07.02.2002
Former [2002/27]SE07.02.2002
Cited inInternational search[AD]GB2161073  (ALZA CORP) [AD] 1-8 * the whole document *;
 [A]GB2185187  (ALZA CORP) [A] 1-8 * the whole document *;
 [Y]WO8907959  (TUCKER JOHN MARK [GB], et al) [Y] 1-8 * claim - *;
 [Y]WO9220377  (ALZA CORP [US]) [Y] 1-8 * claim - * * page 5, line 7 * * page 6, line 12 - line 13 * * page 9, line 20 - line 21 *;
 [Y]WO9300058  (NOVEN PHARMA [US]) [Y] 1-8 * claim - * * page 20, line 21 *;
 [Y]EP0563507  (MLI ACQUISITION CORP II [US]) [Y] 1-8 * claim - *;
 [Y]WO9325168  (THERATECH INC [US]) [Y] 1-8 * claim - * * example 3 *;
 [YD]WO9423707  (HEXAL PHARMA GMBH [DE], et al) [YD] 1-8 * claim - * * page 13, line 4 - line 5 *;
 [Y]  - CHEMICAL ABSTRACTS, (19910923), vol. 115, no. 12, Database accession no. 119907, XP002013566 [Y] 1-8 * abstract *
    [ ] - T. LOFTSSON ET AL., "THE EFFECTS OF CYCLODEXTRINS ON TRANSDERMAL DELIVERY OF DRUGS", EUR. J. PHARM. BIOPHARM., (1991), vol. 37, no. 1, pages 30 - 33
ExaminationWO9210231
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.